TheraRadar
← Back
Data updated: Jul 17, 2026

GLAND PHARMA LIMITED

Pharma
Pharmaceuticals

GLAND PHARMA LIMITED is a pharmaceutical company with 1 FDA-approved products.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

GLAND PHARMA LIMITED's Key Drugs

GLAND PHARMA LIMITED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

GLAND PHARMA LIMITED's Recent FDA Approvals

New NDA/BLA approvals for GLAND PHARMA LIMITED over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

GLAND PHARMA LIMITED's Therapeutic Areas

Disease areas where GLAND PHARMA LIMITED has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

GLAND PHARMA LIMITED Pipeline Snapshot

Active clinical trials for GLAND PHARMA LIMITED across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling